We are the world’s largest publicly-funded international collaboration focused on the development of vaccines to prevent HIV/AIDS. Learn more >
Our sites conduct all phases of clinical trials - from evaluating experimental vaccines for safety and immunogenicity to testing vaccine efficacy. Learn more >
Worldwide, thousands of people have participated in HIV vaccine trials. Volunteers are the heroes of vaccine development. Learn more >
The Hope Clinic is the clinical arm of the Emory Vaccine Research Center, an international Center of Excellence in clinical and translational research in infectious disease (ID) vaccines, treatment, and prevention. The Hope Clinic is also the clinical core for the Emory Center for AIDS Research and one of four sites that are part of the Emory-CDC HIV/AIDS Clinical Trials Unit, a 7-year research award to Emory funded by NIH’s National Institute of Allergy and Infection Diseases and conducted in collaboration with the US Centers for Disease Control and Prevention. Read More.
Antibodies that are able to adhere to the outer shell of HIV can inactivate the virus, and potentially stop infection before it starts. However, HIV is one of the most changeable viruses discovered to date, and the strains in circulation vary widely. An ideal vaccine against HIV would produce antibodies that could inactivate all HIV strains, but the reality is that antibodies against one strain usually don’t work against others. Read more >
We support the next generation of HIV researchers with structured mentoring, projects, training, and networking opportunities. Learn more >
Getting the right test will prevent an incorrect diagnosis of HIV. Your study site or VISP Testing Service can provide the right test. Visit our frequently asked questions for more information.